Metropolis Network Expansion and Revenue Growth Strategy
1a. Core Business Revenue continue to grow by double digit..
Core Business
(incl. Hi-Tech)
12%
286
254
762
+13%
858
23
PPP Contracts
One of the large PPP
Contract ended on 8th
February 2023
65
METROPOLIS
The Pathology Specialist
Covid PCR & Covid Allied
Total Revenues
-59%
39
2%
16
285
291
-31%
8
1%
866
877
2
0
Q3FY23 Q3FY24 9MFY23 9MFY24
Q3FY23 Q3FY24 9MFY23 9MFY24
Q3FY23 Q3FY24 9MFY23 9MFY24
Q3FY23 Q3FY24 9MFY23 9MFY24
✓ Core business revenues have been encouraging with 12% Y-o-Y growth for Q3FY24 indicating a growth trajectory going forward
✓ Revenue growth for Q3FY24 has been impacted to the tune of 1% on account of unprecedented floods in Chennai in Dec 2023
✓ Revenues for Hi-tech grew at mid teen on Y-o-Y basis with margins higher than the company average
✓ Overall revenues growth for Q3 & 9MFY24 has been impacted on account of loss of a large PPP contract in Q4FY23 & dip in revenues from Covid &
Allied Testing
7View entire presentation